 |
 |
| 序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
| 1 | 泓博医药 | 4120.44 | 增持 | 流通A股 | 22.77% | 2026-09-30 |
| 2 | 泓博医药 | 3169.57 | 未变 | 流通A股 | 22.71% | 2026-06-30 |
| 3 | 泓博医药 | 3169.57 | 未变 | 流通A股 | 22.71% | 2026-03-31 |
| 4 | 泓博医药 | 3169.57 | 未变 | 流通A股 | 22.71% | 2025-12-31 |
| 5 | 泓博医药 | 3169.57 | 减持 | 流通A股 | 22.71% | 2025-12-30 |
| 6 | 泓博医药 | 3867.5 | 未变 | 限售流通股 | 27.71% | 2025-09-30 |
| 7 | 泓博医药 | 3867.5 | 未变 | 限售流通股 | 27.71% | 2025-06-30 |
| 8 | 泓博医药 | 3867.50 | 未变 | 受限流通股 | 27.71% | 2025-06-04 |
| 9 | 泓博医药 | 3867.5 | 未变 | 限售流通股 | 27.71% | 2025-03-31 |
| 10 | 泓博医药 | 3867.50 | 未变 | 受限流通股 | 27.71% | 2025-02-18 |
| 11 | 泓博医药 | 3867.50 | 未变 | 受限流通股 | 27.71% | 2025-02-14 |
| 12 | 泓博医药 | 3867.5 | 未变 | 限售流通股 | 27.71% | 2024-12-31 |
| 13 | 泓博医药 | 3867.50 | 未变 | 受限流通股 | 27.71% | 2024-11-08 |
| 14 | 泓博医药 | 3867.5 | 未变 | 限售流通股 | 27.71% | 2024-09-30 |
| 15 | 泓博医药 | 3867.5 | 未变 | 限售流通股 | 27.71% | 2024-06-30 |
| 16 | 泓博医药 | 3867.50 | 未变 | 受限流通股 | 27.71% | 2024-06-28 |
| 17 | 泓博医药 | 3867.50 | 增持 | 受限流通股 | 27.71% | 2024-06-21 |
| 18 | 泓博医药 | 2975.00 | 未变 | 受限流通股 | 27.64% | 2024-05-24 |
| 19 | 泓博医药 | 2975.00 | 未变 | 受限流通股 | 27.64% | 2024-04-18 |
| 20 | 泓博医药 | 2975 | 未变 | 限售流通股 | 27.64% | 2024-03-31 |
| 21 | 泓博医药 | 2975.00 | 未变 | 受限流通股 | 27.64% | 2024-02-08 |
| 22 | 泓博医药 | 2975 | 未变 | 限售流通股 | 27.64% | 2023-12-31 |
| 23 | 泓博医药 | 2975 | 未变 | 限售流通股 | 27.64% | 2023-09-30 |
| 24 | 泓博医药 | 2975 | 增持 | 限售流通股 | 27.64% | 2023-06-30 |
| 25 | 泓博医药 | 2125 | 未变 | 限售流通股 | 27.64% | 2023-03-31 |
| 26 | 泓博医药 | 2125 | 未变 | 限售流通股 | 27.64% | 2022-12-31 |
| 27 | 泓博医药 | 2125.00 | 未变 | 27.64% | 2022-11-01 | |
| 28 | 泓博医药 | 2125 | 未变 | 限售流通股 | 36.88% | 2022-10-19 |
| 29 | 泓博医药 | 2125.00 | 新进 | 非流通外资股 | 36.88% | 2022-03-27 |
| 序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
| 1 | 泓博医药 | 4120.44 | 增持 | 境外法人股 | 25.318% | 2026-09-30 |
| 2 | 泓博医药 | 3169.57 | 未变 | 境外法人股 | 25.237% | 2026-06-30 |
| 3 | 泓博医药 | 3169.57 | 未变 | 境外法人股 | 25.232% | 2026-03-31 |
| 4 | 泓博医药 | 3169.57 | 新进 | 境外法人股 | 25.232% | 2025-12-31 |
|
|